Prenetics Global Reports Strong Q1 Earnings Driven by Subscription-Based Supplement Brand IM8
Prenetics Global reported strong first-quarter revenue growth driven primarily by its subscription-based supplement brand, IM8. Revenue jumped 334% year-over-year to $36 million in Q1, with the company raising full-year IM8 revenue guidance to between $190 million and $210 million for 2026.
Topics: consumer health IM8 brand revenue growth subscription model